TY - GEN
AU - Schiff, David
AU - Kesari, Santosh
AU - de Groot, John
AU - Mikkelsen, Tom
AU - Drappatz, Jan
AU - Coyle, Thomas
AU - Fichtel, Lisa
AU - Silver, Bruce
AU - Walters, Ian
AU - Reardon, David
TI - Phase 2 study of CT-322, a targeted biologic inhibitor of VEGFR-2 based on a domain of human fibronectin, in recurrent glioblastoma
PB - Springer Science and Business Media LLC
SN - 0167-6997
SN - 1573-0646
KW - Pharmacology (medical)
KW - Pharmacology
KW - Oncology
PY - 2015
UR - http://slubdd.de/katalog?TN_libero_mab2
ER -
Download citation